GEN1047 DP clinical trials

First-in-human, open-label, dose-escalation trial with expansion cohorts to evaluate safety of GEN1047 in subjects with malignant solid tumors

This study is testing a new medicine, GEN1047, in women with different types of cancer. We want to find out if it's safe, what the right dose is, and if it helps shrink tumours. It's an early-stage study to see how the medicine works in people for the first time.